Enhanced inducible nitric oxide synthase expression and nitrotyrosine accumulation in experimental granulomatous hepatitis caused by Toxocara canis in mice

Parasite Immunology

Volumn 26, Issue 6-7, 2004, Pages 273-281

  Fan, C K ^a   Lin, Y H ^a   Hung, C C ^b,c   Chang, S F ^a   Su, Kua Eyre ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Granulomatous hepatitis; iNOS; Mouse; NT; Toxocara canis

Indexed keywords

3 NITROTYROSINE; ALANINE AMINOTRANSFERASE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; GIANT CELL; GRANULOMATOUS HEPATITIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TOXOCARA CANIS;

ALANINE TRANSAMINASE; ANIMALS; FEMALE; GIANT CELLS; GRANULOMA; HEPATITIS, ANIMAL; HEPATOCYTES; LARVA; LEUKOCYTES; LIVER; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; TOXOCARA CANIS; TOXOCARIASIS; TYROSINE;

ANIMALIA; CANIS; MURINAE; NEMATODA; TOXOCARA CANIS;

EID: 9644281805     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0141-9838.2004.00708.x     Document Type: Article

References (35)

1. Kerr-Muir MG. Toxocara canis and human health. Br Med J 1994; 309: 5-6.
2. Kayes SG. Human toxocariasis and the visceral larva migrans syndrome: correlative immunopathology. Chem Immunol 1997; 66: 99-124.
3. Ponder D, Marshall GS, Rabalais GP & Wood BP. Radiological case of the month: visceral larva migrans. Am J Dis Child 1991; 145: 699-700.
4. Bhatia V & Sarin SK. Hepatic visceral larva migrans: evolution of the lesion, diagnosis, and role of high-dose albendazole therapy. Am J Gastroenterol 1994; 89: 624-627.
5. Kaushik SP, Hurwitz M, McDonald C & Pavli P. Toxocara canis infection and granulomatous hepatitis. Am J Gastroenterol 1997; 92: 1223-1225.
6. Baldisserotto M, Conchin CF, Scares MG, Araujo MA & Kramer B. Ultrasound findings in children with toxocariasis: report on 18 cases. Pediat Radiol 1999; 29: 316-319.
7. Hartleb M & Januszewski K. Severe hepatic involvement in visceral larva migrans. Eur J Gastroenterol Hepatol 2001; 13: 1245-1249.
8. Kaplan KJ, Goodman ZD & Ishak KG. Eosinophilic granuloma of the liver: a characteristic lesion with relationship to visceral larva migrans. Am J Surg Pathol 2001; 25: 1316-1321.
9. Smith HV. In Parasitic Nematodes: Antigens, Membranes and Genes, ed. Kennedy MW. London: CRC Press; 1991: 116-139.
10. Cuellar C, Fenoy S, del-Aguila C & Guillen L. Isotype-specific immune responses in murine experimental toxocariasis. Mem Inst Oswalde Cruz 2001; 96: 549-553.
11. Fan CK, Lin YH, Du WY & Su KE. Infectivity and pathogenicity of 14-month-cultured embryonated eggs of Toxocara canis in mice. Vet Parasitol 2003; 113: 145-155.
12. Espinoza EY, Muro A, Martin MM, Casanueva P & Perez-Arellano JL. Toxocara canis antigens stimulate the production of nitric oxide and prostaglandin E2 by rat alveolar macrophages. Parasite Immunol 2002; 24: 311-319.
13. Espinoza EY, Perez-Arellano JL, Carranza C, Collia F & Muro A. In vivo inhibition of inducible nitric oxide synthase decreases lung injury induced by Toxocara canis in experimentally infected rats. Parasite Immunol 2002; 24: 511-520.
14. James SL. Role of nitric oxide in parasitic infections. Microbiol Rev 1995; 59: 533-547.
15. Oswald IP, Wynn TA, Sher A & James SL. NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines. Comp Biochem Physiol 1994; 108: 11-18.
16. Kanazawa T, Asahi H, Hata H, Mochida K, Kagei N & Stadecker MJ. Arginine-dependent generation of reactive nitrogen intermediates is instrumental in the in vitro killing of protoscoleces of Echinococcus multilocularis by activated macrophages. Parasite Immunol 1993; 15: 619-623.
17. Rajan TV, Porte P, Yates JA, Keefer L & Shultz LD. Role of nitric oxide in host defense against an extracellular, metazoan parasite, Brugia malayi. Infect Immun 1996; 64: 3351-3353.
18. Hirata M, Hirata K, Kage M, Zhang M, Hara T & Fukuma T. Effect of nitric oxide synthase inhibition on Schistosoma japonicum egg-induced granuloma formation in the mouse liver. Parasite Immunol 2001; 23: 281-289.
19. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by Superoxide dismutase. Arch Biochem Biophys 1992; 298: 431-437.
20. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996; 9: 836-844.
21. Szabo C & Ohshima H. DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1997; 1: 373-385.
22. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR & Matalon S. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 1993; 265: L555-L564.
23. Majano PL, Garcia-Monzon C, Lopez-Cabrera M, et al. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J Clin Invest 1998; 101: 1343-1352.
24. Li J & Billiar TR. Nitric oxide. IV Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 1999; 276: G1069-G1073.
25. O'Lorcain P. The effects of freezing on the viability of Toxocara canis and T. cati embryonated eggs. J Helminthol 1995;69:169-171.
26. Burt AD & Day CP. In Pathology of the Liver, eds Burt AD, Portmann BC, Ishak KG, Scheuer PJ & Anthony PP. London: Churchill Livingstone; 2002: 67-106.
27. Bardon R, Cuellar C & Guillen JL. Larval distribution of Toxocara canis in BALB/C mice at nine weeks and one year post-inoculation. J Helminthol 1994; 68: 359-360.
28. Morikawa A, Kato Y, Sugiyama T, et al. Role of nitric oxide in lipopolysaccharide-induced hepatic injury in D-galactosamine-sensitized mice as an experimental endotoxic shock model. Infect Immun 1999; 67: 1018-1024.
29. Brunet LR, Beall M, Dunne DW & Pearce EJ. Nitric oxide and the Th2 response combine to prevent severe hepatic damage during Schistosoma mansoni infection. J Immunol 1999; 163: 4976-4984.
30. Gagnon C, Leblond FA & Filep JG. Peroxynitrite production by human neutrophils, monocytes and lymphocytes challenged with lipopolysaccharide. FEBS Lett 1998; 431: 107-110.
31. Brennan ML, Wu W, Fu X, et al. A tale of two controversies, defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 2002; 277: 17415-17427.
32. Kim, YM, Talanian RV & Billiar TR. Nitric oxide inhibits apoptosis by preventing increase in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997; 272; 31138-31148.
33. Bowman JW, Winterrowd CA, Friedman AR, et al. Nitric oxide mediates the inhibitory effects of SDPNFLRFamide, a nematode FMRFamide-related neuropeptide, in Ascaris suum. J Neurophysiol 1995; 74: 1880-1888.
34. Battista S, Bar F, Mengozzi G, et al. Evidence of an increased nitric oxide production in primary biliary cirrhosis. Am J Gastroenterol 2001; 96: 869-875.
35. Jaiswal M, LaRusso NF, Burgart LJ & Gores GJ. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 2000; 60: 184-190.